IGF1 and sarcopenia: In the context of improving sarcopenia in the elderly, EMS has been found to promote the secretion of myokines, particularly insulin-like growth factor-1 (IGF-1), and enhance downstream signaling pathways (Leal, Lopes & Batista, 2018; Sajer, Guardiero & Scicchitano, 2018).